Cromos CEO outlines advantages of Central and Eastern Europe for clinical trials Why should international sponsors look at Central and Eastern Europe (CEE) as locations for their clinical trials? Want to find out more about the advantages of locating your study in this region and partnering with an international CRO which has 16 years of experience across CEE? Cromos Pharma’s CEO Vlad Bogin, MD, FACP outlines some of the benefits in a recent interview
Top 5 reasons to locate your next clinical trial in Hungary Hungary is placed 10th worldwide in terms of the number of trials conducted in the country and 4th in Europe (based on population-proportional patient numbers). Each year approximately 20,000 patients participate in clinical trials. Cromos Pharma established its office in Budapest, Hungary in 2016. 5 Top Reasons to Choose Hungary An EU member state, Hungary
World Cancer Day 2021: Cromos Pharma is committed to supporting clinical research to make cancer breakthroughs Each 4th February, #WorldCancerDay aims to raise awareness of the global personal, social and economic burden of cancer. It promotes better understanding of cancer and highlights risk factors and ways in which we can all reduce our chances of certain cancers. It advocates for continued clinical research into cancers and effective therapies and treatments. Global Cancer Stats:
